Snapshot A 19-year-old male college student presents to the clinic complaining of a burning sensation with urination as well as purulent urethral discharge. He admits to rarely using condoms during sexual intercourse, and does not recall the last time he was tested for sexually-transmitted infections. Urinalysis is positive for leukocyte esterase and a Gram stain shows intracellular diplococci within polymorphonuclear neutrophils. Introduction Classification Neisseria Gram-negative diplococci often intracellular within neutrophils Epidemiology incidence the second most common bacterial sexually-transmitted infection (after Chlamydia) location genital tract risk factors unprotected sexual intercourse Pathogenesis mechanism molecular biology pili facilitate attachment to mucosal surfaces antigenic variation IgA protease allows invasion of mucosal surfaces contains lipooligosaccharides (LOS) with strong endotoxin activity invasion of mucosal surfaces results in inflammation transmission sexual perinatal Associated conditions septic arthritis neonatal conjunctivitis (2-5 days after birth) prophylaxis with erythromycin eye drops pelvic inflammatory disease (PID) Fitz-Hugh-Curtis syndrome Presentation Symptoms dysuria purulent discharge fever prostatitis (men) endocervicitis (women) urethritis Studies Labs Cervical and urethral culture Thayer-Martin agar selects for growth of Neisseria contains vancomycin, trimethoprim, colistin, and nystatin to inhibit growth of Gram-positive organisms, Gram-negative organisms except for Neisseria, and fungi Nucleic acid amplification testing (NAAT) Histology Gram stain of a cervical swab Gram-negative kidney-shaped diplococci Differential Chlamydia distinguishing factor visualization of intracytoplasmic inclusions (reticulate bodies) on histology Urinary tract infection distinguishing factor lack of growth on Thayer-Martin agar Genital herpes simplex distinguishing factor painful vesicles and ulcers Treatment Medical IM ceftriaxone add azithromycin or doxycycline for possible concomitant chlamydial infection Complications Pelvic inflammatory disease (PID) may include salpingitis, endometritis, hydrosalpinx, tubo-ovarian abscess risk factor for ectopic pregnancy, infertility, chronic pelvic pain, and adhesions Fitz-Hugh-Curtis Syndrome perihepatitis infection and inflammation of liver capsule adhesions of peritoneum to liver Comparison with N. meningitidis Characteristics N. gonorrhoeae N. meningitidis Appearance Kidney-bean shaped diplococci Oxidase test Positive Polysaccharide capsule No Yes Fermentation Glucose ("Gonococci") Maltose and Glucose ("MeninGococci") Transmission Sex Respiratory Vaccine No (due to rapid antigenic variation) Yes β-lactamase production Common Rare IgA protease production Yes
QUESTIONS 1 of 3 1 2 3 Previous Next Lab Values Blood Hematologic Cerebrospinal Sweat, Urine, and BMI Blood, Plasma, Serum Reference Range ALT 8-20 U/L Amylase, serum 25-125 U/L AST 8-20 U/L Bilirubin, serum (adult) Total // Direct 0.1-1.0 mg/dL // 0.0-0.3 mg/dL Calcium, serum (Ca2+) 8.4-10.2 mg/dL Cholesterol, serum Rec: < 200 mg/dL Cortisol, serum 0800 h: 5-23 μg/dL //1600 h: 3-15 μg/dL 2000 h: ≤ 50% of 0800 h Creatine kinase, serum Male: 25-90 U/LFemale: 10-70 U/L Creatinine, serum 0.6-1.2 mg/dL Electrolytes, serum Sodium (Na+) 136-145 mEq/L Chloride (Cl-) 95-105 mEq/L Potassium (K+) 3.5-5.0 mEq/L Bicarbonate (HCO3-) 22-28 mEq/L Magnesium (Mg2+) 1.5-2.0 mEq/L Estriol, total, serum (in pregnancy) 24-28 wks // 32-36 wks 30-170 ng/mL // 60-280 ng/mL 28-32 wk // 36-40 wks 40-220 ng/mL // 80-350 ng/mL Ferritin, serum Male: 15-200 ng/mLFemale: 12-150 ng/mL Follicle-stimulating hormone, serum/plasma Male: 4-25 mIU/mL Female: premenopause: 4-30 mIU/mL midcycle peak: 10-90 mIU/mL postmenopause: 40-250 pH 7.35-7.45 PCO2 33-45 mmHg PO2 75-105 mmHg Glucose, serum Fasting: 70-110 mg/dL2-h postprandial:<120 mg/dL Growth hormone - arginine stimulation Fasting: <5 ng/mLProvocative stimuli: > 7ng/mL Immunoglobulins, serum IgA 76-390 mg/dL IgE 0-380 IU/mL IgG 650-1500 mg/dL IgM 40-345 mg/dL Iron 50-170 μg/dL Lactate dehydrogenase, serum 45-90 U/L Luteinizing hormone, serum/plasma Male: 6-23 mIU/mL Female: follicular phase: 5-30 mIU/mL midcycle: 75-150 mIU/mL postmenopause 30-200 mIU/mL Osmolality, serum 275-295 mOsmol/kd H2O Parathyroid hormone, serume, N-terminal 230-630 pg/mL Phosphatase (alkaline), serum (p-NPP at 30° C) 20-70 U/L Phosphorus (inorganic), serum 3.0-4.5 mg/dL Prolactin, serum (hPRL) < 20 ng/mL Proteins, serum Total (recumbent) 6.0-7.8 g/dL Albumin 3.5-5.5 g/dL Globulin 2.3-3.5 g/dL Thyroid-stimulating hormone, serum or plasma .5-5.0 μU/mL Thyroidal iodine (123I) uptake 8%-30% of administered dose/24h Thyroxine (T4), serum 5-12 μg/dL Triglycerides, serum 35-160 mg/dL Triiodothyronine (T3), serum (RIA) 115-190 ng/dL Triiodothyronine (T3) resin uptake 25%-35% Urea nitrogen, serum 7-18 mg/dL Uric acid, serum 3.0-8.2 mg/dL Hematologic Reference Range Bleeding time 2-7 minutes Erythrocyte count Male: 4.3-5.9 million/mm3Female: 3.5-5.5 million mm3 Erythrocyte sedimentation rate (Westergren) Male: 0-15 mm/hFemale: 0-20 mm/h Hematocrit Male: 41%-53%Female: 36%-46% Hemoglobin A1c ≤ 6 % Hemoglobin, blood Male: 13.5-17.5 g/dLFemale: 12.0-16.0 g/dL Hemoglobin, plasma 1-4 mg/dL Leukocyte count and differential Leukocyte count 4,500-11,000/mm3 Segmented neutrophils 54%-62% Bands 3%-5% Eosinophils 1%-3% Basophils 0%-0.75% Lymphocytes 25%-33% Monocytes 3%-7% Mean corpuscular hemoglobin 25.4-34.6 pg/cell Mean corpuscular hemoglobin concentration 31%-36% Hb/cell Mean corpuscular volume 80-100 μm3 Partial thromboplastin time (activated) 25-40 seconds Platelet count 150,000-400,000/mm3 Prothrombin time 11-15 seconds Reticulocyte count 0.5%-1.5% of red cells Thrombin time < 2 seconds deviation from control Volume Plasma Male: 25-43 mL/kgFemale: 28-45 mL/kg Red cell Male: 20-36 mL/kgFemale: 19-31 mL/kg Cerebrospinal Fluid Reference Range Cell count 0-5/mm3 Chloride 118-132 mEq/L Gamma globulin 3%-12% total proteins Glucose 40-70 mg/dL Pressure 70-180 mm H2O Proteins, total < 40 mg/dL Sweat Reference Range Chloride 0-35 mmol/L Urine Calcium 100-300 mg/24 h Chloride Varies with intake Creatinine clearance Male: 97-137 mL/minFemale: 88-128 mL/min Estriol, total (in pregnancy) 30 wks 6-18 mg/24 h 35 wks 9-28 mg/24 h 40 wks 13-42 mg/24 h 17-Hydroxycorticosteroids Male: 3.0-10.0 mg/24 hFemale: 2.0-8.0 mg/24 h 17-Ketosteroids, total Male: 8-20 mg/24 hFemale: 6-15 mg/24 h Osmolality 50-1400 mOsmol/kg H2O Oxalate 8-40 μg/mL Potassium Varies with diet Proteins, total < 150 mg/24 h Sodium Varies with diet Uric acid Varies with diet Body Mass Index (BMI) Adult: 19-25 kg/m2 Calculator ( ) xy AC 7 8 9 ÷ 4 5 6 × 1 2 3 - 0 . = + Sorry, this question is for PEAK Premium Subscribers only Upgrade to PEAK Sorry, this question is for PEAK Premium Subscribers only Upgrade to PEAK (M1.MC.74) A 26-year-old male presents to his primary care physician with complaints of burning with urination, penile discharge, and intermittent fevers. A urethral smear shows gram negative diplococci within white blood cells. The organism grows well when cultured on Thayer-Martin agar. The patient is prescribed a course of ceftriaxone and the infection resolves without further complication. One year later, the patient returns with the same infection. Which of the following best explains this lack of lasting immunity? Review Topic QID: 106692 1 Exotoxin release 0% (0/10) 2 Antigenic variation 90% (9/10) 3 Polysaccharide capsule 0% (0/10) 4 Bruton's agammaglobulinemia 0% (0/10) 5 Lack of necessary vaccination 0% (0/10) M1 Select Answer to see Preferred Response PREFERRED RESPONSE 2